Varicose veins can pose medical and cosmetic concerns for up to 25% of women and 15% of men. They develop when the valves normally responsible for preventing backflow in veins become weakened, or the walls of the veins enlarge. These veins then twist and swell in an attempt to accommodate extra blood, appearing as dark purple or blue lines and/or bulges beneath the skin. Some people also experience pain, aching, or burning, especially at night.
Asclera is an FDA-approved therapy specifically designed to treat this unsightly and sometimes painful condition. With a pinpoint injection of a chemical called Polidocanol, Dr. Rokhsar targets problematic veins, dissolving their inner lining. This causes the vessel walls to adhere to one another, closing the space and prompting the body to eventually reabsorb the vein.
Prior to the procedure, a numbing cream will be applied to the area. Treatment then consists of a series of injections into target veins, taking around half an hour. Asclera also has anesthetic properties, making the procedure comfortable for most patients. Patients can typically return to their schedule within half an hour after treatment is completed.
*Results may vary.
Because varicose veins often cover large areas, patients often need 2-3 treatment sessions, with the possibility of maintenance sessions every 1-5 years for new problem areas.
Full results of Asclera treatments can be seen within the next few weeks, so treatment should ideally be planned about three months before the desired outcome is to be expected.
Asclera has been used in Europe to treat spider and reticular veins in the legs for over 40 years, with over 5 million successful treatments. Side effects may include pain at the injection site, bruising or hematoma, and in rare cases a severe allergic reaction.
The typical Asclera patient has already tried traditional measures such as compression stockings, leg elevation exercises, and reducing prolonged standing. Though most men and women are good candidates for sclerotherapy, those with certain blood or thromboembolic vascular conditions, or those taking specific medications may not be suitable. Please be sure to discuss any current medical issues and medications with Dr. Rokhsar prior to treatment.
Upper East Side Manhattan Office
121 East 60th Street, Suite 8AB New York, NY 10022
(212) 285-1110
Long Island Office
901 Stewart Ave, Suite 240, Garden City, NY 11530
(516) 512-7616
Dr. Cameron Rokhsar, MD, FAAD, FAACS, is the founder and medical director of the New York Cosmetic, Skin, & Laser Surgery Center. Dr. Rokhsar is a graduate of Harvard College and NYU School of Medicine. Dr. Rokhsar is double board certified in dermatology and micrographic dermatologic surgery, being one of the few select dermatologists in the country who is also fellowship trained in laser surgery. A researcher and innovator, Dr. Rokhsar is the creator of the non-surgical nose job and has been instrumental in the research and development of laser systems such as the Fraxel, CO2, Mirady, Vbeam, Themitight, and Ulthera devices. An Associate Professor of Dermatology at Mount Sinai Hospital in NYC, Dr. Rokhsar actively teaches the cosmetic dermatology clinic to the resident at Mount Sinai. An expert injector of fillers, and a trainer for many companies, patients fly in from around the world to see Dr. Rokhsar in his Garden City and Manhattan offices in New York.
Dr. Rokhsar was chosen by
magazine as a top dermatologist in its Best Doctors 2017, 2018, 2019, 2020, 2021, 2022 and 2023 issues.
